India, Oct. 11 -- - Two-day international conclave focuses on genomics, CAR-T therapy, transplantation and responsible AI to strengthen precision care and patient access -
- Childhood blood disorders, survivorship and infection management feature across three parallel scientific programmes -
Gurugram: Fortis Memorial Research Institute (FMRI), Gurugram, today inaugurated HemeNext 2.0, a two-day international scientific conclave bringing together Indian and global experts to translate advances in blood science into more precise, accessible, and affordable care.
India's cancer burden was estimated at 14.6 lakh new cases in 2022 by the Indian Council of Medical Research-National Cancer Registry Programme (ICMR-NCRP). Lymphoid leukaemia was ...